Saturday, December 4

Pfizer shares rose almost 11%, following the announcement of the effectiveness of the anti-Covid-19 pill

While Merck shares fell 9.9%, weighing on the healthcare sector of the S & P500 on Wall Street. This pharmaceutical company also developed an antiviral pill but in clinical trials it was shown to reduce the risk of hospitalization and death by up to 50%, implying that the development of Pfizer significantly improved effectiveness.

Meanwhile, the main indices on Wall Street closed with a triple record. The Dow Jones finished with a gain of 0.57% to 36,328.41 points, while the Nasdaq technology rose 0.20% to 15,971.58 units and the S&P 500 composite index 0.37% to 4,697.57 points.